Histoire d’impact
Lecture 3 m
10 septembre 2024
GESTION DES ANTIMICROBIENS
prod:prod_dcx-login
Le besoin
- Bloodstream infections cause an estimated 250 000 deaths annually in North America and Europe combined1
- S. aureus and MRSA continue to be leading causes of bloodstream infections and are associated with increased length of stay and hospital costs2
- Current culture-based lab testing methods for gram-positive blood culture bottles require an additional 24–72 hours for determination of S. aureus or MRSA
- Early antimicrobial treatment for patient management.2
1 Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501–9.
Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA,
2 Parcel B, et al. Rapid molecular testing for Staphylococcus aureus bacteraemia improves clinical management. (Les tests moléculaires rapides pour la bactériémie à Staphylococcus aureus améliorent la prise en charge clinique.) Microbiol J Med. 2020 Mar;.
Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA,
2 Parcel B, et al. Rapid molecular testing for Staphylococcus aureus bacteraemia improves clinical management. (Les tests moléculaires rapides pour la bactériémie à Staphylococcus aureus améliorent la prise en charge clinique.) Microbiol J Med. 2020 Mar;.
La solution
The Xpert MRSA/SA Blood Culture test is a qualitative in vitro diagnostic test designed for rapid and simultaneous detection of S. aureus and methicillin-resistant S. aureus (MRSA) directly from gram-positive blood cultures.
The Xpert MRSA/SA Blood Culture test delivers:
The Xpert MRSA/SA Blood Culture test delivers:
- Efficient laboratories with on-demand workflows that require minimal hands-on time
- Optimized therapy with fast informed treatment decisions to help reduce empirical prescribing
L’impact
- Reduced result reporting turnaround time median of 24 hours, enabling earlier patient management review2
- Enable earlier treatment with faster time to results3
- Help reduce length of stay3
2 Parcel B, et al. Rapid molecular testing for Staphylococcus aureus bacteraemia improves clinical management. (Les tests moléculaires rapides pour la bactériémie à Staphylococcus aureus améliorent la prise en charge clinique.) Microbiol J Med. 2020 Mar;.
3 Goff D, et al. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureu sblood culture test in
patients with S. aureus bacteremia. Clin Infect Dis. 2010
3 Goff D, et al. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureu sblood culture test in
patients with S. aureus bacteremia. Clin Infect Dis. 2010
